Mar 14, 2019

2019/03/21 Journal Club

Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.